XBKK
VIBHA
Market cap573mUSD
Nov 12, Last price
1.43THB
Name
Vibhavadi Medical Center PCL
Chart & performance
P/E
11.38
P/S
3.43
EPS
0.13
Div yield, %
3.50%
Shrs. gr., 5y
-1.82%
Rev. gr., 5y
-1.39%
Revenues
5.62b
-34.29%
Net income
1.69b
+142.61%
CFO
1.49b
-17.20%
Dividend
May 06, 20260.06 THB/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Vibhavadi Medical Center Public Company Limited, a Bangkok, Thailand-based entity, manages Vibhavadi Hospital. Its operations are divided into two main segments: Hospital services and other ventures. The company delivers a full spectrum of medical care, supplemented by hotel and room rental accommodations. It also participates in the beauty industry. This firm was established in 1986.
Key people
Nikom Wairatpanij
Chairman of the Board · since 2019
Chairman of the Executive Board, Executive Director · since 2019
Yongyut Domesuriya
Vice President - Accounting and Financial, Director - Accounting and Finance · since 2011
Piyaphan Tharanat
Managing Director of Development and Training, Executive Director, Director
Phijit Wiriyamettakul
Managing Director, Executive Director · since 2019
Chaisit Khupviwat
Deputy Managing Director, Executive Director, Director · since 2009
Virayut Chaopricha
Deputy Managing Director of Hospital, Executive Director · since 2014
Yada Putthkayon
Executive Director, Director
Sasithorn Norakrai
Company Secretary, Managing Director of General Management · since 2003
Chamnan Chanapai
Director · since 2012
Executive Director, Director
Director · since 2012
Phromphong Phirabun
Managing Director of Hospitals, Executive Director, Director · since 2009
Bavornphan Rathpresert
Executive Director, Director
Racha Somburanasin
Director · since 2012
Woraphan Unchark
Director · since 2012
Rukkagee Kanjanapitak
Non-Executive Director · since 2015
Non-Executive Director · since 2022
Pramuk Unachak
Non-Executive Director · since 2019
Prasert Sriuranpong
Independent Director
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||